report cover1

Diagnostic Radiopharmaceuticals and Contrast Media Market - Global Industry, Analysis, Size, Share, Growth, Trends, and Forecasts 2023-2030

Diagnostics radiopharmaceuticals and contrast media play crucial roles in modern medical imaging, aiding healthcare professionals in obtaining detailed and accurate information for diagnostic purposes. Radiopharmaceuticals, typically used in nuclear medicine, contain radioactive substances that emit gamma rays, allowing for the visualization of internal structures and functions within the body. These substances are administered to patients either orally or intravenously, targeting specific organs or tissues. Contrast media, on the other hand, are substances that enhance the visibility of certain structures during imaging procedures like X-rays, computed tomography (CT), and magnetic resonance imaging (MRI). Non-ionic contrast media, in particular, are preferred due to their lower risk of adverse reactions. Both radiopharmaceuticals and contrast media contribute significantly to the advancement of medical imaging technologies, enabling healthcare professionals to diagnose conditions accurately and plan appropriate treatment strategies for their patients.

Radiopharmaceuticals are compounds labeled with radioactive isotopes, such as technetium-99m or iodine-131, which emit gamma rays. These isotopes decay and emit radiation that is detected by specialized imaging devices, providing functional information about organs or tissues. Common procedures involving radiopharmaceuticals include positron emission tomography scans, single-photon emission computed tomography, and bone scans.

Global Diagnostic Radiopharmaceuticals and Contrast Media Market – Competitive Landscape

On December 5, 2023, Novartis invested USD 84.6 million in a new radiopharmaceutical production base in China. On November 13, 2023, Telix and Mauna Kea Technologies to expand collaboration in Urologic Oncology Surgery. On June 29, 2023, ITM secured USD 280 million to boost radiopharmaceutical pipeline and isotope production. On October 10, 2022, RadioMedix announced USD 40 million for a targeted therapy platform.

Some of the Key Players in the Global Diagnostic Radiopharmaceuticals and Contrast Media Market Include –

  • GE Healthcare
  • Cardinal Health Inc
  • Bayer AG
  • Bracco SPA
  • Lantheus
  • Siemens Healthineers
  • Lilly
  • Advanced Accelerator Applications
  • Guerbet Group
  • Ntp Radioisotopes
  • Jubilant Pharma

Global Diagnostic Radiopharmaceuticals and Contrast Media Market – Growth Drivers

Ongoing advancements in imaging technologies drive the demand for diagnostic radiopharmaceutical and contrast media, as newer techniques often require more sophisticated agents to enhance imaging resolution and accuracy. The increasing incidence of chronic diseases, such as cardiovascular disorders and cancer, fuels the need for diagnostic imaging procedures. According to World Health Organization noncommunicable diseases kill 41 million people each year equivalent to 74% of all death globally. Diagnostic radiopharmaceuticals and contrast media play a pivotal role in the early detection and monitoring of these conditions. With a global demographic shift towards an aging population, there is a growing demand for diagnostic procedures to address age-related health issues. Diagnostic imaging becomes essential for diagnosing and managing various age-related diseases, contributing to the market growth. The broadening scope of diagnostic imaging applications, including oncology, neurology, and cardiology, propels the demand for specialized radiopharmaceuticals and contrast media tailored to different medical fields, thereby driving market growth. Public awareness campaigns and healthcare initiatives promoting early disease detection contribute to the adoption of diagnostic imaging procedures. This, in turn, boosts the demand for pharmaceuticals and contrast media in facilitating accurate diagnoses at early stages.

Global Diagnostic Radiopharmaceuticals and Contrast Media Market – Restraints

The use of diagnostic radiopharmaceuticals and contrast media is associated with potential safety concerns, including allergic reactions and, in some cases, rare severe adverse events/ these concerns may limit their adoption, especially in patients with a history of allergies or compromised renal function. The cost associated with diagnostic imaging procedures using radiopharmaceuticals and contrast media can be a significant restraint. According to the National Center for Biotechnology Information (NCBI), imaging costs in healthcare systems are between USD 200 billion to 250 billion per year. High expenses may limit access to these advanced diagnostic tools, particularly in regions with limited healthcare budgets or inadequate insurance coverage. In some regions, reimbursement policies for diagnostic imaging procedures may be limited or insufficient. This can pose a challenge for healthcare providers and impact the accessibility of these technologies, hindering market growth. Radiopharmaceuticals often have short half-lives, requiring on-site production facilities and specialized handling. This logistical challenge can limit their availability and use in certain healthcare settings affecting the broader market adoption. The radioactive nature of some radiopharmaceuticals raises ethical and environmental considerations. Proper disposal and management of radioactive waste pose challenges, and concerns about environmental impact may lead to regulatory restrictions, affecting market growth.

Global Diagnostic Radiopharmaceuticals and Contrast Media Market – Opportunities

Increasing use of diagnostic radiopharmaceuticals and contrast media in research applications, including drug development and disease understanding, creates new opportunities for market expansion beyond traditional diagnostic imaging. The growing demand for positron emission tomography imaging, which heavily relies on radiopharmaceuticals, provides a significant opportunity for market growth. PET scans offer detailed functional information driving their adoption in various medical specialties. The increasing focus on healthcare infrastructure development in emerging markets and untapped regions presents opportunities for market players to expand their reach and cater to the growing demand for diagnostic imaging procedures.

Global Diagnostic Radiopharmaceuticals and Contrast Media Market – Geographical Insight

The market for global diagnostic radiopharmaceuticals and contrast media is segmented into regions such as North America, Latin America, Europe, Asia-Pacific, the Middle East & Africa. North America is the largest market for diagnostic radiopharmaceuticals and contrast media due to advanced healthcare infrastructure, significant research and development activities, and high healthcare expenditure in the region. Europe is a significant market for diagnostics radiopharmaceuticals and contrast media, driven by established healthcare systems, increasing prevalence of chronic diseases, and a proactive approach towards adopting advanced diagnostic technologies. The Asia-Pacific region presents substantial growth opportunities, fueled by rising healthcare awareness, increasing disposable income, and ongoing efforts to enhance healthcare infrastructure.

Global Diagnostic Radiopharmaceuticals and Contrast Media Market – Key Development

  • On September 8, 2023, Positron Corporation announced the start of a clinical study of affinity PET-CT device.
  • On May 30, 2023, the U.S. FDA approved Blue Earth diagnostics POSLUMA® injection, the first Radiohybrid PSMA-targeted PET imaging agent for prostate cancer.
  • On October 7, 2022, Duchem Bio launched radiopharmaceutical for prostate cancer diagnosis in Kora.
Complete the form below and we'll get back to you shortly
Table of Content
Complete the form below and we'll get back to you shortly

Research Methodology: Aspects

Market research is a crucial tool for organizations aiming to navigate the dynamic landscape of customer preferences, business trends, and competitive landscapes. At Cognizance Market Research, acknowledging the importance of robust research methodologies is vital to delivering actionable insights to our clientele. The significance of such methodologies lies in their capability to offer clarity in complexity, guiding strategic management with realistic evidence rather than speculation. Our clientele seek insights that excel superficial observations, reaching deep into the details of consumer behaviours, market dynamics, and evolving opportunities. These insights serve as the basis upon which businesses craft tailored approaches, optimize product offerings, and gain a competitive edge in an ever-growing marketplace.

The frequency of information updates is a cornerstone of our commitment to providing timely, relevant, and accurate insights. Cognizance Market Research adheres to a rigorous schedule of data collection, analysis, and distribution to ensure that our reports reflect the most current market realities. This proactive approach enables our clients to stay ahead of the curve, capitalize on emerging trends, and mitigate risks associated with outdated information.

Our research process is characterized by meticulous attention to detail and methodological rigor. It begins with a comprehensive understanding of client objectives, industry dynamics, and research scope. Leveraging a combination of primary and secondary research methodologies, we gather data from diverse sources including surveys, interviews, industry reports, and proprietary databases. Rigorous data analysis techniques are then employed to derive meaningful insights, identify patterns, and uncover actionable recommendations. Throughout the process, we remain vigilant in upholding the highest standards of data integrity, ensuring that our findings are robust, reliable, and actionable.

Key phases involved in in our research process are mentioned below:


Understanding Clients’ Objectives:

Extensive Discussions and Consultations:

  • We initiate in-depth discussions and consultations with our clients to gain a comprehensive understanding of their objectives. This involves actively listening to their needs, concerns, and aspirations regarding the research project.
  • Through these interactions, we aim to uncover the underlying motivations driving their research requirements and the specific outcomes they hope to achieve.

Industry and Market Segment Analysis:

  • We invest time and effort in comprehensively understanding our clients’ industry and market segment. This involves conducting thorough research into market trends, competitive dynamics, regulatory frameworks, and emerging opportunities or threats.
  • By acquiring a deep understanding of the broader industry landscape, we can provide context-rich insights that resonate with our clients’ strategic objectives.

Target Audience Understanding:

  • We analyze our clients’ target audience demographics, behaviors, preferences, and needs to align our research efforts with their consumer-centric objectives. This entails segmenting the audience based on various criteria such as age, gender, income level, geographic location, and psychographic factors.
  • By understanding the nuances of the target audience, we can tailor our research methodologies to gather relevant data that illuminates consumer perceptions, attitudes, and purchase intent.


Identifying Challenges and Opportunities:

  • We proactively identify the challenges and opportunities facing our clients within their respective industries. This involves conducting SWOT (Strengths, Weaknesses, Opportunities, Threats) analyses and competitive benchmarking exercises.
  • By identifying potential obstacles and growth drivers, we can provide strategic recommendations that help our clients navigate complexities and capitalize on emerging opportunities effectively.

Grasping Specific Goals:

  • We delve into the intricacies of our clients’ objectives to gain clarity on the specific goals they aim to accomplish through the research. This entails understanding their desired outcomes, such as market expansion, product development, or competitive analysis.
  • By gaining a nuanced understanding of our clients’ goals, we can tailor our research approach to address their unique challenges and opportunities effectively.

Data Collection:


Primary Research Process:

  • Surveys: We design and administer surveys tailored to capture specific information relevant to our clients’ objectives. This may involve employing various survey methodologies, such as online, telephone, or face-to-face interviews, to reach target audiences effectively.
  • Interviews: We conduct structured or semi-structured interviews with key stakeholders, industry experts, or target consumers to gather in-depth insights and perspectives on relevant topics. These interviews allow us to probe deeper into specific issues and uncover valuable qualitative data.
  • Focus Groups: We organize focus group discussions with carefully selected participants to facilitate interactive discussions and gather collective opinions, attitudes, and preferences. This qualitative research method provides rich contextual insights into consumer behaviors and perceptions.
  • Observations: We conduct observational research by directly observing consumer behaviors, interactions, and experiences in real-world settings. This method enables us to gather objective data on consumer actions and reactions without relying on self-reported information.

Secondary Research Process:

  • Literature Review: We conduct comprehensive literature reviews to identify existing studies, academic articles, and industry reports relevant to the research topic. This helps us gain insights into previous research findings, theoretical frameworks, and best practices.
  • Industry Reports: We analyze industry reports published by reputable trade associations (whitepapers, research studies, etc.), and government agencies (U.S. Census Bureau, Bureau of Labor Statistics, and Securities and Exchange Commission etc.) to obtain macro-level insights into market trends, competitive landscapes, and industry dynamics.
  • Government Publications: We review government publications, such as economic reports, regulatory documents, and statistical databases, to gather relevant data on demographics, market size, consumer spending patterns, and regulatory frameworks.
  • Online Databases: We leverage online databases, such as industry portals, and academic repositories (PubMed Central (PMC), ScienceDirect, SSRN (Social Science Research Network), Directory of Open Access Journals (DOAJ), NCBI, etc.), to access a wide range of secondary data sources, including market statistics, financial data, and industry analyses.



Data Analysis:

The data analysis phase serves as a critical juncture where raw data is transformed into actionable insights that inform strategic decision-making. Through the utilization of analytical methods such as statistical analysis and qualitative techniques like thematic coding, we uncover patterns, correlations, and trends within the data. By ensuring the integrity and validity of our findings, we strive to provide clients with accurate and reliable insights that accurately reflect the realities of the market landscape.


Transformation of Raw Data:

  • Upon collecting the necessary data, we transition into the data analysis phase, where raw data is processed and transformed into actionable insights. This involves organizing, cleaning, and structuring the data to prepare it for analysis.

Utilization of Analytical Methods:

  • Depending on the research objectives, we employ a diverse range of analytical methods to extract meaningful insights from the data. These methods include statistical analysis, trend analysis, regression analysis, and qualitative coding.

Statistical Analysis:

  • Statistical tools are instrumental in uncovering patterns, correlations, and trends within the data. By applying statistical techniques such as descriptive statistics, hypothesis testing, and multivariate analysis, we can discern relationships and derive valuable insights.

Qualitative Analysis Techniques:

  • In addition to quantitative analysis, we leverage qualitative analysis techniques to gain deeper insights from qualitative data sources such as interviews or open-ended survey responses. One such technique is thematic coding, which involves systematically categorizing and interpreting themes or patterns within qualitative data.

Integrity and Validity Maintenance:

  • Throughout the analysis process, we maintain a steadfast commitment to upholding the integrity and validity of our findings. This entails rigorous adherence to established methodologies, transparency in data handling, and thorough validation of analytical outcomes.

Data Validation:

The final phase of our research methodology is data validation, which is essential for ensuring the reliability and credibility of our findings. Validation involves scrutinizing the collected data to identify any inconsistencies, errors, or biases that may have crept in during the research process. We employ various validation techniques, including cross-referencing data from multiple sources, conducting validity checks on survey instruments, and seeking feedback from independent experts or peer reviewers. Additionally, we leverage internal quality assurance protocols to verify the accuracy and integrity of our analysis. By subjecting our findings to rigorous validation procedures, we instill confidence in our clients that the insights they receive are robust, reliable, and trustworthy.


Importance of Data Validation:

  • Data validation is the final phase of the research methodology, crucial for ensuring the reliability and credibility of the findings. It involves a systematic process of reviewing and verifying the collected data to detect any inconsistencies, errors, or biases.

Scrutiny of Collected Data:

  • The validation process begins with a thorough scrutiny of the collected data to identify any discrepancies or anomalies. This entails comparing data points, checking for outliers, and verifying the accuracy of data entries against the original sources.

Validation Techniques:

  • Various validation techniques are employed to ensure the accuracy and integrity of the data. These include cross-referencing data from multiple sources to corroborate findings, conducting validity checks on survey instruments to assess the reliability of responses, and seeking feedback from independent experts or peer reviewers to validate the interpretation of results.

Internal Quality Assurance Protocols:

  • In addition to external validation measures, internal quality assurance protocols are implemented to further validate the accuracy of the analysis. This may involve conducting internal audits, peer reviews, or data validation checks to ensure that the research process adheres to established standards and guidelines.
- Get Started -

Get insights that lead to new growth opportunities

Need a Custom Report?

We can customize every report – free of charge – including purchasing stand-alone sections or country-level reports

Want to Buy a Report but have a Limited Budget?

We help clients to procure the report or sections of the report at their budgeted price. Kindly click on the below to avail

Business Development

small c popup.png
Buy Now
small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
small c popup.png
Complete the form below and we'll get back to you shortly
Ask an Expert